Home
Laser combination therapy not significantly more effective for anti-VEGF-resistant DME than anti-VEGF monotherapy
Laser combination therapy not significantly more effective for anti-VEGF-resistant DME than anti-VEGF monotherapy
While anti-vascular endothelial growth factor (VEGF) therapy is the first-line treatment for diabetic macular edema (DME), it can be less effective in some patients. Results from a prospective study did not show that laser combination therapy was significantly more effective for anti-VEGF-resistant DME than anti-VEGF monotherapy alone. Alternative therapeutic approaches...
Read MoreQuizzes
Contact Info
© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved